Document is current
Any future updates will be listed below
-
Authors
Forino, Nicholas M. https://orcid.org/0000-0003-1715-6741
Woo, Jia Zheng
Zaug, Arthur J.
Jimenez, Arcelia Gonzalez
Edelson, Eva https://orcid.org/0009-0005-6431-7191
Cech, Thomas R.
Rouskin, Silvi https://orcid.org/0000-0003-2042-6642
Stone, Michael D. https://orcid.org/0000-0002-2060-4501
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM095850, R35GM153235)
- License Information
-
More Information
Article History
Received: 4 October 2023
Accepted: 10 January 2025
First Online: 22 January 2025
Competing interests
: T.R.C. is a scientific advisor for Eikon Therapeutics, Storm Therapeutics, lincSwitch Therapeutics, and Somalogic, Inc. The remaining authors declare no competing interests.
